Filing metadata

Accession number
0001628280-21-025130
Form type
Form 4
Filer
Aurinia Pharmaceuticals Inc.
CIK
CIK 1600620
Filed
Dec 15, 2021
Reporting period
Dec 13, 2021
Description
Insider transaction

Explore SEC Filings Hub